Outsourced Pharma Webinars

1. Vaccine Development: Strategic Approach & Response During Pandemics 2/24/2021

   Over the past decade, outbreaks of H1N1 influenza, Sars-Cov, Ebola, and MERS have sparked ongoing conversations about strategic approaches and responses to pandemics and epidemics. Now with the spread of SARS-CoV-2 intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring these life-saving drugs to market faster without impacting product quality, safety, or efficacy.

2. Next-Gen, Cloud-Based Architecture For Centralized Process Data Analytics 2/2/2021

   Explore the advantages of cloud-based software in manufacturing data management and how to cost effectively scale your IT infrastructure to improve productivity, economic growth and sustainability.

3. Best Practices: Establishing Data Visibility Across Sponsor/CMO Networks 2/2/2021

   In this webinar industry leaders identify novel ways to collaborate and improve adherence to cGMP requirements and ensure compliant quality production. Learn how you can establish reasonable expectations for data transparency and sharing in Sponsor/CMO relationships to ensure effective data management across the supply chain.

4. Best Practices: Using Validatable Software To Support CPV (Continued Process Verification) And Tech Transfer 2/2/2021

   In this webinr a panel of experts  share their technology transfer, CPV, and validation experiences with and without the support of software. Discover how digital systems help overcome operational and regulatory hurdles through the sharing of accurate and timely product and process knowledge between development and manufacturing teams and across manufacturing sites.

5. Best Practices: Ensuring Process Data Integrity Throughout The Product Life Cycle 2/2/2021

   In this webinar a panel of experts from discuss how now more than ever the bio/pharma industry needs to adopt strategies to improve the gathering, analysis, reporting and sharing of process data to establish indisputable integrity and improve decision making.

6. Manufacturing Innovation Across New Modalities 2/1/2021

   The successful outcomes delivered by cell and gene therapies coupled with emergence of modalities across nucleic acid therapeutics and microbiomes pose the next challenge for innovators to make these new modalities available at scale. In this webinar, we review and present key areas of technology innovation that have the potential to reshape how these advanced therapeutics are manufactured at scale.

7. Clinical Readiness – Practical And Innovative Solutions For AAV Development And Manufacturing 2/1/2021

   What are the current challenges and future promises of adeno-associated virus (AAV), lentivirus, and lipid nanoparticles in gene therapies? George Buchman, Ph.D., Vice President of Preclinical & Process Development at Catalent Gene Therapy, discusses specific case studies for neuromuscular degenerative indications, AAV technology and manufacturing, strategies for navigating the current regulatory environments in the U.S. and Europe.

8. Technology Integrators In Cell And Gene Therapy: Powering Innovation 2/1/2021

   The cell and gene therapy markets are seeing growth in the use of allogeneic and autologous cell therapies as well as viral vectors for gene therapy and ex-vivo transduction of the cell therapies. Both require investments in technologies to enhance safety and efficacy as well as reduce production costs. In this webinar, Julien Meissonnier, Vice President and Chief Scientific Officer, discusses innovative approaches, technology disrupters, and more.

9. How To Commercially Scale T-cell Allogeneic Therapies 2/1/2021

   Jesse Trekker, PhD, Business Development Director at Catalent Cell & Gene Therapy, discusses an innovative manufacturing methodology and fill/finish approaches to accelerate T-cell therapies to the commercial readiness phase.

10. Northway Biotech Expands To The US: Boston Facility Grand Opening 1/21/2021

    Many biologics developers utilize CDMOs to augment their existing supply or for development and manufacturing needs, but choosing the right outsourcing partner can be overwhelming.